HanjiVax: Miracle Drug against CR-20!

          Biochemists at the Royal Hanji Institute of Science & Technology  (RHIST) have developed a drug identified as H1N1 based on recent mRNA science, allowing for more efficient delivery of immune system strengthening in the fight against CR-20, a contagious respiratory illness. Chief Biochemist, Dr. Ko Hyung-San and his team relied on the principle of RNA organic chemistry to compress the biochemical instruction.  This became the next revolutionizing discovery after the advent of CRISPR-Cas-9, a gene editing technology.  At the palace, King Kang Yi Jun and his royal administration plan to commence a large-scale campaign nationwide as well as abroad in foreign embassies called HanjiVax.  

 Latest release of HanjiVax in a laboratory at the Royal Hanji Institute of Science & Technology.

          So far, 143 cases have been reported, and healthcare workers continue to treat the masses.  The death toll now stands at 901 as local governors across the country stress the importance of isolation policies and hygiene as part of the plan to overcome the epidemic.